Literature DB >> 27064648

Generation of human induced pluripotent stem cells using non-synthetic mRNA.

L Rohani1, C Fabian1, H Holland2, Y Naaldijk1, R Dressel3, H Löffler-Wirth4, H Binder4, A Arnold5, A Stolzing6.   

Abstract

Here we describe some of the crucial steps to generate induced pluripotent stem cells (iPSCs) using mRNA transfection. Our approach uses a V. virus-derived capping enzyme instead of a cap-analog, ensuring 100% proper cap orientation for in vitro transcribed mRNA. V. virus' 2'-O-Methyltransferase enzyme creates a cap1 structure found in higher eukaryotes and has higher translation efficiency compared to other methods. Use of the polymeric transfection reagent polyethylenimine proved superior to other transfection methods. The mRNA created via this method did not trigger an intracellular immune response via human IFN-gamma (hIFN-γ) or alpha (hIFN-α) release, thus circumventing the use of suppressors. Resulting mRNA and protein were expressed at high levels for over 48h, thus obviating daily transfections. Using this method, we demonstrated swift activation of pluripotency associated genes in human fibroblasts. Low oxygen conditions further facilitated colony formation. Differentiation into different germ layers was confirmed via teratoma assay. Reprogramming with non-synthetic mRNA holds great promise for safe generation of iPSCs of human origin. Using the protocols described herein we hope to make this method more accessible to other groups as a fast, inexpensive, and non-viral reprogramming approach.
Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Induced pluripotent stem cell; Reprogramming; mRNA

Mesh:

Substances:

Year:  2016        PMID: 27064648     DOI: 10.1016/j.scr.2016.03.008

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  10 in total

1.  Human Induced Pluripotent Stem Cell Production and Expansion from Blood using a Non-Integrating Viral Reprogramming Vector.

Authors:  Arun Sharma; Michael Mücke; Christine E Seidman
Journal:  Curr Protoc Mol Biol       Date:  2018-04

Review 2.  An Insight into DNA-free Reprogramming Approaches to Generate Integration-free Induced Pluripotent Stem Cells for Prospective Biomedical Applications.

Authors:  Manash P Borgohain; Krishna Kumar Haridhasapavalan; Chandrima Dey; Poulomi Adhikari; Rajkumar P Thummer
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

3.  Production of endothelial progenitor cells from skin fibroblasts by direct reprogramming for clinical usages.

Authors:  Phuc Van Pham; Ngoc Bich Vu; Thuy Thi-Thanh Dao; Ha Thi-Ngan Le; Lan Thi Phi; Ngoc Kim Phan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2016-10-24       Impact factor: 2.416

Review 4.  A researcher's guide to the galaxy of IRESs.

Authors:  Ilya M Terenin; Victoria V Smirnova; Dmitri E Andreev; Sergey E Dmitriev; Ivan N Shatsky
Journal:  Cell Mol Life Sci       Date:  2016-11-16       Impact factor: 9.207

Review 5.  Concise Review: Molecular Cytogenetics and Quality Control: Clinical Guardians for Pluripotent Stem Cells.

Authors:  Leili Rohani; Adiv A Johnson; Pooyan Naghsh; Derrick E Rancourt; Henning Ulrich; Heidrun Holland
Journal:  Stem Cells Transl Med       Date:  2018-09-14       Impact factor: 6.940

Review 6.  Employing Endogenous NSCs to Promote Recovery of Spinal Cord Injury.

Authors:  Sumei Liu; Zhiguo Chen
Journal:  Stem Cells Int       Date:  2019-05-05       Impact factor: 5.443

7.  Highly efficient induction of primate iPS cells by combining RNA transfection and chemical compounds.

Authors:  Toshiaki Watanabe; Shun Yamazaki; Nao Yoneda; Haruka Shinohara; Ikuo Tomioka; Yuichiro Higuchi; Mika Yagoto; Masatsugu Ema; Hiroshi Suemizu; Kenji Kawai; Erika Sasaki
Journal:  Genes Cells       Date:  2019-06-17       Impact factor: 1.891

Review 8.  Cell-Based Therapy Manufacturing in Stirred Suspension Bioreactor: Thoughts for cGMP Compliance.

Authors:  Suman C Nath; Lane Harper; Derrick E Rancourt
Journal:  Front Bioeng Biotechnol       Date:  2020-11-26

Review 9.  RNA-Based Strategies for Cell Reprogramming toward Pluripotency.

Authors:  Anaëlle Bailly; Ollivier Milhavet; Jean-Marc Lemaitre
Journal:  Pharmaceutics       Date:  2022-01-28       Impact factor: 6.321

Review 10.  Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through.

Authors:  Narmatha Gurumoorthy; Fazlina Nordin; Gee Jun Tye; Wan Safwani Wan Kamarul Zaman; Min Hwei Ng
Journal:  Biomedicines       Date:  2022-01-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.